Machine-learning derived algorithms for prediction of radiographic progression in early axial spondyloarthritis.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 15 04 2022
accepted: 27 06 2022
medline: 28 3 2023
pubmed: 7 10 2022
entrez: 6 10 2022
Statut: ppublish

Résumé

To compare machine learning (ML) to traditional models to predict radiographic progression in patients with early axial spondyloarthritis (axSpA). We carried out a prospective French multicentric DESIR cohort study with 5 years of follow-up that included patients with chronic back pain for <3 years, suggestive of axSpA. Radiographic progression was defined as progression at the spine (increase of at least 1 point of mSASSS scores/2 years) or at the sacroiliac joint (worsening of at least one grade of the mNY score between 2 visits). Statistical analyses were based on patients without any missing data regarding the outcome and variables of interest (295 patients).Traditional modelling: we performed a multivariate logistic regression model (M1); then variable selection with stepwise selection based on Akaike Information Criterion (stepAIC) method (M2), and Least Absolute Shrinkage and Selection Operator (LASSO) method (M3).ML modelling: using "SuperLearner" package on R, we modelled radiographic progression with stepAIC, LASSO, random forest, Discrete Bayesian Additive Regression Trees Samplers (DBARTS), Generalized Additive Models (GAM), multivariate adaptive polynomial spline regression (polymars), Recursive Partitioning And Regression Trees (RPART) and Super Learner. Accuracy of these models was compared based on their 10-fold cross-validated AUC (cv-AUC). 10-fold cv-AUC for traditional models were 0.79 and 0.78 for M2 and M3, respectively. The three best models in the ML algorithms were the GAM, the DBARTS and the Super Learner models, with 10-fold cv-AUC of: 0.77, 0.76 and 0.74, respectively. Two traditional models predicted radiographic progression as good as the eight ML models tested in this population.

Identifiants

pubmed: 36200930
pii: 18670
doi: 10.55563/clinexprheumatol/mm2uzu
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

727-734

Auteurs

Romain Garofoli (R)

ECAMO Team, INSERM U1153: Clinical Epidemiology and Biostatistics, Université de Paris, France. romaingarofoli@gmail.com.

Matthieu Resche-Rigon (M)

ECSTRRA Team, INSERM U1153: Clinical Epidemiology and Biostatistics, Université de Paris, and SBIM, Saint-Louis Hospital, APHP, Paris, France.

Christian Roux (C)

ECAMO Team, INSERM U1153: Clinical Epidemiology and Biostatistics, Université de Paris, and Rheumatology Department, Cochin Hospital, APHP.5, Paris, France.

Désirée van der Heijde (D)

Leiden University Medical Center (LUMC), Leiden, The Netherlands.

Maxime Dougados (M)

ECAMO Team, INSERM U1153: Clinical Epidemiology and Biostatistics, Université de Paris, and Rheumatology Department, Cochin Hospital, APHP.5, Paris, France.

Anna Moltó (A)

ECAMO Team, INSERM U1153: Clinical Epidemiology and Biostatistics, Université de Paris, and Rheumatology Department, Cochin Hospital, APHP.5, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH